In May 2025, the New England Journal of Medicine published the first head-to-head clinical trial comparing two of the most effective anti-obesity medications on the market: tirzepatide (Zepbound) and semaglutide (Wegovy). This was the phase 3b open label extension of the SURMOUNT-5 clinical trial involving 751 non-diabetic obese patients. The main finding was that tirzepatide led to significantly more weight loss than semaglutide over 72
Understanding the role of nutrition in weight loss is the key to unlocking your body’s fat-burning potential because your food choices directly influence whether your body stores or releases fat. Understanding this connection allows you to take control of your weight loss journey. By learning how different foods interact with your metabolism, you can strategically
